Search for: "Merck Sharp & Dohme LTD"
Results 41 - 60
of 61
Sorted by Relevance
|
Sort by Date
27 Jun 2010, 6:00 pm
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
23 Feb 2016, 1:53 am
| US trade secrets | Trends in IP Data | EPO's new Chief Economist | GIFs and copyright | Katcall for new positions in the IPKat team | Star Wars IP.Never too late 83 [week ending on Sunday 31 January] – The AmeriKat from the Silicon Valley | INGRES conference on developments in European IP law 2015 - patents | Economics of UK creative industries |Stretchline v H&M | Merck KGaA v Merck Sharp & Dohme |… [read post]
28 May 2013, 5:05 am
Merck Sharp & Dohme Corp., No. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
16 May 2023, 7:33 am
See Merck Sharp & Dohme Corp. v. [read post]
5 Aug 2009, 7:59 am
EPO - Get your house in order - understand how applications have changed over the last 12 months, and how your company needs to adapt to gain first time patent approval 2009 confirmed speakers include: Bo Hammer Janssen, Senior Patent Counsel, Novozymes Nicolas Ruiz, Head of IP, Esteve Dr Mandar Kodgule, Head, Intellectual Property and Strategic Planning, Wockhardt Ltd Dr William Heggie, CSO, Hovione James Horgan, Assistant Counsel, Merck, Sharpe &… [read post]
21 Dec 2017, 7:09 am
This work will encompass multiple research projects with the current proposals looking at: the role of price differentials, sector specific impacts and enforcement impacts.BREAKING: CJEU holds that SPCs cannot be obtained on the basis of an "end of procedure notice" pursuant to Article 3(b) SPC RegulationMr Justice Arnold referred two questions to the CJEU on the SPC Regulation in Merck Sharp & Dohme v Comptroller-General of Patents [2016]… [read post]
26 Aug 2019, 12:09 pm
Supreme Court in the next term.Africa Correspondent Chijioke Okorie reports on Raconteur Productions Limited v Dioni VisionsEntertainment Limited and 2 Others, heard before the Lagos Division of the Federal High Court of Nigeria, concerning the possibility of copyright infringement of a ‘screenplay’, which is not specifically mentioned or defined in the Nigerian Copyright Act as a protected work.Platform Liability -Former GuestKat Mirko Brüß examines another case referred… [read post]
3 Aug 2011, 3:31 am
General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
15 Oct 2018, 12:52 am
The Court of Appeal clarified in Merck v Merck Sharpe & Dohme [2017] EWCA Civ 1834. that this targeting should be considered on an objective basis. [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) Cubicin (Daptomycin) – US: Cubist Pharmaceuticals to oppose Teva’s attempt to add inequitable conduct defense in patent infringement action (SmartBrief) Dorzolamide/Timolol – Netherlands: Preliminary injunction judge rules UK invalidity decision not sufficient to rule non-negligible chance that (Dutch part of) patent will be invalidated in proceedings on the merits: Merck Sharp & Dohme v. [read post]
23 Nov 2015, 2:40 pm
****************** PREVIOUSLY, ON NEVER TOO LATE Never Too Late 72 [week ending on Sunday 15 November] – Merck Sharp & Dohme v Ono Pharmaceutical | Warner-Lambert Co LLC v Sandoz GmbH, Sandoz Ltd and Lloyds Pharmcacy Ltd | Economics of internet trolls | UK IPO scammer scammed | Video conferencing at the EPO | Warner-Lambert v Pfizer in France | African Ministerial Conference in IP |… [read post]
7 Jul 2021, 11:44 pm
The Patentees filed two PTE applications, each of which was based on different goods on the ARTG: Brand Name OPDIVO® KEYTRUDA® Active ingredient nivolumab pembrolizumab Australian sponsor Bristol-Myers Squibb Australia Pty Ltd Merck Sharp & Dohme (Australia) Pty Ltd Relationship between sponsor and patentees Related to one of the patentees Not related to either patentee Date goods containing the drug were first included on ARTG 11 January… [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Atripla (Emtricitabine) - US: District Court S D New York: Patent infringement suit filed following a Paragraph IV Certification: Merck, Sharp & Dohme Corp. et al. v. [read post]
17 Feb 2010, 5:10 am
Merck, Sharp & Dohme Corp. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott Laboratories et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott Laboratories et al… [read post]
23 Sep 2022, 9:39 am
selected address issues such as SPC protection for combination products, double patenting, prosecution history estoppel and the influence of declarations made by the patentee in parallel proceedings, the possibility for national courts to request technical opinions from the EPO under Art. 25 EPC, and the disappearance of the cautio iudicatum solvi that was sometimes required from foreign plaintiffs launching (patent) proceedings in Belgium.SPC’s for combination products: still more questions… [read post]
30 Mar 2022, 4:31 am
Ltd [2022] FCAFC 39 (Ono) and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2022] FCAFC 40 (MSD). [read post]
